CMBA
FATE icon

C.M. Bidwell & Associates’s Fate Therapeutics FATE Stock Holding History

C.M. Bidwell & Associates’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30
Closed -$49 – 472
2024
Q4 		$49 Hold
30
– – ﹤0.01% 484
2024
Q3 		$105 Hold
30
– – ﹤0.01% 498
2024
Q2 		$98 Hold
30
– – ﹤0.01% 473
2024
Q1 		$220 Hold
30
– – ﹤0.01% 474
2023
Q4 		$112 Hold
30
– – ﹤0.01% 486
2023
Q3 		$64 Hold
30
– – ﹤0.01% 517
2023
Q2 		$143 Sell
30
-24,578
-100% -$136K ﹤0.01% 502
2023
Q1 		$140K Buy
24,608
+24,479
+18,976% +$148K 0.11% 174
2022
Q4 		$1.3K Buy
129
+99
+330% +$1.86K ﹤0.01% 473
2022
Q3 		$1K Hold
30
– – ﹤0.01% 454
2022
Q2 		$1K Hold
30
– – ﹤0.01% 461
2022
Q1 		$1K Buy
+30
New +$1.16K ﹤0.01% 499

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return